This is our 2nd year using the New Registration System!
For detail information regarding PPS, please visit the main website: http://www.utexas.edu/pharmacy/ce/conferences/pps/index.html
• If you attended PPS last year, then you should already have a profile in the system and you can use that to register.
• If you do not remember the email you used or password, use the options listed on the log-in page to have the system send that information.
Date: Sep 13, 2014 07:00 AM - Sep 14, 2014 04:00 PM
Fee
CE Hours
CE Units
Registration closes on Oct 30, 2014 11:59 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
- Pharmacy Technicians
Accreditation(s)
“This statement contains information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor®.”
|
|
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
|
Requirements for CE Credit
Registration closes on Oct 30, 2014
at 11:59 PM
Registration Closed
Registration Closed
Speaker(s)/Author(s)
William Riffee, BSPharm., Ph.D.
|
Activity Number
0067-0000-14-010-L04-P/TCE Hours
Registration Closed
Objectives
- Define new pregnancy risks categories.
- Describe how to identify the teratogenicity of medications.
- Identify medications that should be avoided during pregnancy and lactation.
- Discuss approaches to counseling about medications for which no human pregnancy data exists.
Speaker(s)/Author(s)
Thomas Hale, R.Ph., Ph.D.
|
Activity Number
0067-0000-14-011-L01-P/TCE Hours
Registration Closed
Objectives
- Review recent developments in anticoagulation therapy
- List the key prescribing points, safety concerns, and monitoring parameters for each anticoagulant.
- Identify options for reversing anticoagulants.
- Discuss switching between anticoagulation agents.
Speaker(s)/Author(s)
Bryson Duhon, Pharm.D.
|
Activity Number
0067-0000-14-012-L01-P/TCE Hours
Registration Closed
Objectives
- Explain how the Affordable Care Act will impact current pharmacy practice.
- Recognize the impact the Affordable Care Act may have on consumers, insurance companies, and small business.
Speaker(s)/Author(s)
David Warner, PhD
|
Activity Number
0067-0000-14-013-L03-P/TCE Hours
Registration Closed
Objectives
- Interpret new lipid recommendations using patient case studies.
- Interpret new hypertension recommendations using patient case studies.
- Describe evidence-based treatment strategies for hypertension and hyperlipidemia based on case studies.
Speaker(s)/Author(s)
James A. Karboski, Pharm.D.
Brief Bio : James A. Karboski, Pharm.D. is a Clinical Associate Professor of Pharmacy and Assistant Division Head in the Health Outcomes and Pharmacy Practice Division at the University of Texas at Austin College of Pharmacy. He holds the Neill B. Walsdorf Fellowship in Pharmacy. Dr. Karboski earned a Bachelor of Pharmacy degree from Washington State University in 1985. Subsequently, Dr. Karboski earned his Doctor of Pharmacy degree from the University of Texas at Austin and the University of Texas Health Sciences Center at San Antonio in 1987. He continued his training in Texas where he completed a Clinical Sciences Fellowship in Pharmacokinetics at the University of Texas at Austin. |
Activity Number
0067-0000-14-014-L01-P/TCE Hours
Registration Closed
Objectives
- Describe the pharmacology, adverse effects, drug interactions therapeutic uses and dosing of selected prescription drugs recently marketed.
Speaker(s)/Author(s)
Leroy C. Knodel, Pharm.D.
|
Activity Number
0067-0000-14-015-L01-P/TCE Hours
Registration Closed
Objectives
- Examine the changes and challenges that affect the relationships between Alzheimer's patients and their family/loved ones.
- Describe community-based, long-term services that are available for Alzheimer's patients.
- Identify resources and services to recommend to caregivers of Alzheimer's patients.
Speaker(s)/Author(s)
Jennifer Scott
|
Activity Number
0067-0000-14-016-L01-P/TCE Hours
Registration Closed
Objectives
- Describe the practical goals of an antimicrobial stewardship.
- Discuss local applications of such stewardships, for both community and institutional settings.
- Review current prophylactic antibiotic measures seen in practice.
Speaker(s)/Author(s)
Elizabeth O. Hand, Pharm.D., BCIDP
|
Activity Number
0067-0000-14-017-L03-P/TCE Hours
Registration Closed
Registration closes on Oct 30, 2014
at 11:59 PM
Registration Closed
Registration Closed
Objectives
- Describe the pathophysiology of Rheumatoid Arthritis (RA), including any characteristic clinical features.
- Discuss current therapies used to decrease the progression of RA.
Speaker(s)/Author(s)
Christopher Parker, D.O., FACP, FACR
|
Activity Number
0067-0000-14-018-L01-P/TCE Hours
Registration Closed
Objectives
- Cite recent changes in pharmacy laws and rules and their impact on daily practice.
- Critically discuss practice scenarios regarding Texas pharmacy laws ad rules.
Speaker(s)/Author(s)
Gay Dodson, R.Ph.
|
Activity Number
0067-0000-14-019-L03-P/TCE Hours
Registration Closed
Objectives
- Explain the reasons behind abuse deterrent opioid formulations.Identify the requirements for abuse deterrent opioid formulations.
- Identify the requirements for abuse deterrent opioid formulations.
- Identify the methods used to create abuse deterrent formulations.
- Identify the methods of studying abuse deterrent formulations.
Speaker(s)/Author(s)
Laurajo Ryan, PharmD, MSc, BCPS, CDE, Pharm.D., MSc, BCPS, CDE
|
Activity Number
0067-0000-14-020-L01-P/TCE Hours
Registration Closed
Objectives
- Define the pathophysiology and diagnosis of celiac disease.
- Recognize signs and symptoms of celiac disease and referral opportunities.
- Identify potential sources of gluten in medications.
Speaker(s)/Author(s)
Harish Gagneja, MD, AGAF
|
Activity Number
0067-0000-14-021-L01-P/TCE Hours
Registration Closed
Objectives
- Low testosterone - real diagnosis or not
- Benign Prostatic Hyperplasia- Identify medications and when to treat
- Update on the utility of Prostate- Specific Antigen (PSA)
- Erectile Dysfunction (ED) update
Speaker(s)/Author(s)
Bryan Kansas, MD
|
Activity Number
0067-0000-14-022-L01-P/TCE Hours
Registration Closed
Objectives
- Define Traumatic Brain Injury (TBI) and some common causes.
- Identify signs and symptoms associated with TBI.
- Discuss the management of TBI, both short-term and long-term.
- Describe Texas law requiring evaluation for concussion and ho it impacts patient care.
Speaker(s)/Author(s)
Kimberly Arlinghaus, MD
|